| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 07/11/2002 | WO2002008286A3 Zinc finger domain recognition code and uses thereof |
| 07/11/2002 | WO2001096580A3 Method for modifying plant morphology, biochemistry and physiology using cytokinin oxidases |
| 07/11/2002 | WO2001094548A3 Hy2 family of bilin reductases |
| 07/11/2002 | WO2001085930A3 Methods and compounds for modulating melanocortin receptor ligand binding and activity |
| 07/11/2002 | WO2001085207A3 Modulation of antigen processing using phagocytic cells |
| 07/11/2002 | WO2001081616A3 Method for screening of microorganisms under nutrient limited conditions |
| 07/11/2002 | WO2001081412A3 Isolated human transporter proteins, nucleic acid molecules encoding the same, and uses thereof |
| 07/11/2002 | WO2001079445A3 Pluripotent cells comprising allogenic nucleus and mitochondria |
| 07/11/2002 | WO2001078756A3 Agent for postoperative use after the removal of bone tumours |
| 07/11/2002 | WO2001046443A3 Proteases |
| 07/11/2002 | WO2001044478A9 CORE 1 β3-GALACTOSYL TRANSFERASES AND METHODS OF USE THEREOF |
| 07/11/2002 | WO2001043540A3 Methods for producing transgenic animals |
| 07/11/2002 | WO2001016322A3 Compositions and methods for inhibiting human immunodeficiency virus infection by down-regulating human cellular genes |
| 07/11/2002 | WO2001011035A9 Monoclonal antibodies for human cytochrome p450 3a4 and human cytochrome p450 2c9 |
| 07/11/2002 | WO2001005837A9 Method for assaying compounds affecting smooth muscle contractile state |
| 07/11/2002 | WO2000073321A9 Human tumor necrosis factor receptor tr10 |
| 07/11/2002 | WO2000064488A9 Somatic transgene immunization and related methods |
| 07/11/2002 | WO2000063438A3 Method of classifying a thyroid carcinoma using differential gene expression |
| 07/11/2002 | WO2000058472A9 Isolated dna encoding cullin regulators roc1 and roc2, isolated proteins encoded by the same, and methods utilizing the same |
| 07/11/2002 | WO2000052187A9 Enhanced system for construction of adenovirus vectors |
| 07/11/2002 | US20020092040 DNA sequences coding for enzymes capable of facilitating the synthesis of linear alpha-1, 4 glucans in plants, fungi and microorganisms |
| 07/11/2002 | US20020092035 Cell cultures for use in monitoring preferential gene expression in cells |
| 07/11/2002 | US20020092033 Turn animal bladder into a bioreactor, for gene expression of any exogenous biomolecule such as blood clotting factors, hormones; also animal models of bladder cancer; easy to purify from urine |
| 07/11/2002 | US20020091448 Tissue engineered testicular prosthesis and use thereof |
| 07/11/2002 | US20020091249 Human tumor suppressor polypeptides |
| 07/11/2002 | US20020091247 Polycyclic aromatic hydrocarbon induced molecules |
| 07/11/2002 | US20020091246 Dendritic cell co-stimulatory molecules |
| 07/11/2002 | US20020091244 Nucleotide sequences for use in diagnosis and treatment of cancer and immunological disorders |
| 07/11/2002 | US20020091229 Photopolymerizable biodegradable hydrogels as tissue contacting materials and controlled-release carriers |
| 07/11/2002 | US20020091101 Immunoisolation of a cell; use of biomedically pure, p-GlcNAc of high molecular weight and consistent properties. |
| 07/11/2002 | US20020091096 Nucleic acid, including DNA, immunization against disease caused by infection by a strain of Chlamydia employing a vector, containing a nucleotide sequence encoding a lorf2 protein of a strain of Chlamydia |
| 07/11/2002 | US20020091084 Human calcineurin B-like protein (CAB) and polynucleotides which identify and encode CAB. |
| 07/11/2002 | US20020090741 Method of separating cells from a sample |
| 07/11/2002 | US20020090725 Collagen; for use in forming tissues and organs |
| 07/11/2002 | US20020090724 Activation of regulatory T cells by alpha-melanocyte stimulating hormone |
| 07/11/2002 | US20020090723 Generating preferential cell cultures; isolate blastocyst, culture, recover cells |
| 07/11/2002 | US20020090722 Pluripotent mammalian cells |
| 07/11/2002 | US20020090721 Mucin-containing delivery vehicle for the transport of biomolecules |
| 07/11/2002 | US20020090720 Separating preferential particles from solution; obtain sample, detect particle in sample, expose sample to acoustic vibration, recover particles from fluid |
| 07/11/2002 | US20020090717 Cell lines and constructs useful in production of E1-deleted adenoviruses in absence of replication competent adenovirus |
| 07/11/2002 | US20020090703 Mammalian protein phosphatases |
| 07/11/2002 | US20020090695 Kunitz-type protease inhibitor polynucleotides, polypeptides, and antibodies |
| 07/11/2002 | US20020090693 Novel human sodium-dependent phosphate cotransporter |
| 07/11/2002 | US20020090674 Nucleic acids, proteins, and antibodies |
| 07/11/2002 | US20020090673 Nucleic acids, proteins, and antibodies |
| 07/11/2002 | US20020090672 Nucleic acids, proteins, and antibodies |
| 07/11/2002 | US20020090671 Bone stimulating factor |
| 07/11/2002 | US20020090635 Compositions and methods for the release of nucleic acid molecules from solid matrices |
| 07/11/2002 | US20020090615 Nucleic acids, proteins, and antibodies |
| 07/11/2002 | US20020090609 Diagnostics and therapy of diseases associated with HHV-8 infections |
| 07/11/2002 | US20020090603 Methods of differentiating and protecting cells by modulating the P38/MEF2 pathway |
| 07/11/2002 | US20020090391 Resorbable extracellular matrix for reconstruction of cartilage |
| 07/11/2002 | US20020090373 ADAMTS polypeptides, nucleic acids encoding them, and uses thereof |
| 07/11/2002 | US20020090364 Cells designed as traps and their use as medicines |
| 07/11/2002 | US20020090362 Immunotherapy using cytotoxic t lymphocytes (ctl) |
| 07/11/2002 | US20020090358 Chronic lymphocytic leukemia treatment |
| 07/11/2002 | US20020090357 Contacting a naive T cell with a stimulatory signal and an appropriate amount of a combination of Vitamin D3 and Dexamethasone, wherein contacting results in differentiation to a regulatory T cell |
| 07/11/2002 | DE10064948C1 Verfahren zur Dezellularisierung von Fremdmaterial zur Herstellung von Bioprothesen und Vorrichtung zur Durchführung des Verfahrens A process for decellularization of foreign material to the manufacture of bioprostheses and apparatus for carrying out the method |
| 07/11/2002 | DE10061864A1 Rekombinante Schweineleberesterase, deren Verwendung sowie ein Verfahren zu deren Herstellung Recombinant porcine liver esterase, to their use and to a process for their preparation |
| 07/11/2002 | CA2689741A1 Latent human tuberculosis model, diagnostic antigens, and methods of use |
| 07/11/2002 | CA2558640A1 Spliceosome mediated rna trans-splicing |
| 07/11/2002 | CA2467434A1 Reversible mhc multimer staining for functional purification of antigen-specific t cells |
| 07/11/2002 | CA2434136A1 Mammalian tribbles signaling pathways and methods and reagents related thereto |
| 07/11/2002 | CA2434118A1 Spliceosome mediated rna trans-splicing |
| 07/11/2002 | CA2433800A1 Antibodies to insulin-like growth factor i receptor |
| 07/11/2002 | CA2433782A1 Proteins and nucleic acids encoding same |
| 07/11/2002 | CA2433559A1 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 07/11/2002 | CA2433296A1 Focused acoustic ejection cell sorting system and method |
| 07/11/2002 | CA2433176A1 Mammalian cancer cell and transgenic mammal carrying human protooncogene and kit for diagnosing cancer using said protooncogene |
| 07/11/2002 | CA2432902A1 Gene disruption methodologies for drug target discovery |
| 07/11/2002 | CA2432426A1 Recombinant protective protein from streptococcus pneumoniae |
| 07/11/2002 | CA2432339A1 Identification of the genetic determinants of the polymorphic cyp3a5 expression |
| 07/11/2002 | CA2430667A1 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 07/10/2002 | EP1221484A2 Biosynthetic osteogenic proteins and osteogenic devices containing them |
| 07/10/2002 | EP1221483A1 NF-AT polypeptides and polynucleotides |
| 07/10/2002 | EP1221478A2 Polynucleotides coding for the type III, II and I erythrose reductases from Trichosporonoides megachilensis and uses thereof for the production of erythritol |
| 07/10/2002 | EP1221477A2 Transfection of vertebrate cells e.g. by homologous recombination |
| 07/10/2002 | EP1221476A2 Culture medium for CHO-cells and adapted CHO-cells |
| 07/10/2002 | EP1221342A2 Method for seperating cells from a sample |
| 07/10/2002 | EP1221053A2 A method for isolation of prostatic epithelial cells from semen |
| 07/10/2002 | EP1220952A2 Converting diploidy to haploidy for genetic diagnosis |
| 07/10/2002 | EP1220947A2 50 human secreted proteins |
| 07/10/2002 | EP1220946A2 Methods of utilizing the tt virus |
| 07/10/2002 | EP1220943A2 Stable expression of polymorphous forms of human cytochrome p450 2d6 as an analytic in the pre-clinical development of medicaments |
| 07/10/2002 | EP1220942A1 41 human secreted proteins |
| 07/10/2002 | EP1220935A1 Synthetic and chimeric promoters, expression cassettes, plasmids, vectors, transgenic plants and seeds containing them, and method for producing them |
| 07/10/2002 | EP1220934A2 Methods for making recombinant proteins using apoptosis inhibitors |
| 07/10/2002 | EP1220931A1 Dna encoding prost 07 polypeptide |
| 07/10/2002 | EP1220930A2 Transacylases of the paclitaxel biosynthetic pathway |
| 07/10/2002 | EP1220929A1 Human ubiquitin protease |
| 07/10/2002 | EP1220926A2 Recombinant megalomicin biosynthetic genes and uses thereof |
| 07/10/2002 | EP1220925A1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 07/10/2002 | EP1220923A2 FACTOR IX/FACTOR IXa ANTIBODIES AND ANTIBODY DERIVATIVES |
| 07/10/2002 | EP1220922A2 Treatment of chronic inflammatory disease by inhibiting sub-groups of activated t-cells |
| 07/10/2002 | EP1220921A1 Nucleic acid sequences of hyperplasia and tumours of the thyroid |
| 07/10/2002 | EP1220918A2 Hepatoma-derived growth factor-like proteins, polynucleotides encoding them and methods of use |
| 07/10/2002 | EP1220917A1 P-glycoproteins from macaca fascicularis and uses thereof |
| 07/10/2002 | EP1220915A1 Splice variant of head trauma induced cytoplasmatic calcium binding protein |
| 07/10/2002 | EP1220914A1 Human g-protein coupled receptor |
| 07/10/2002 | EP1220913A1 G protein-coupled receptor up-regulated in prostate cancer and uses thereof |